Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$452,369
-$153,810 QoQ
Shares Held
114,524
+27.9% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. MDXG ranks #189 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $452,369 | 114,524 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $606,179 | 89,539 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $592,176 | 84,839 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $484,541 | 79,303 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $388,998 | 51,184 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $446,810 | 46,446 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $232,008 | 39,257 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $261,586 | 37,747 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $253,930 | 32,978 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $255,838 | 29,172 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $386,581 | 53,029 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $359,934 | 54,453 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $180,716 | 52,996 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $124,441 | 44,763 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $91,957 | 32,041 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $86,524 | 24,935 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $114,146 | 24,235 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $131,388 | 21,753 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $319,065 | 52,651 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $691,190 | 55,251 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $666,410 | 64,700 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $300,548 | 33,100 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||